Next Article in Journal
Advice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and Disallowing Studies Where Bioavailability Is Not Proven
Next Article in Special Issue
Therapeutic Potential of Novel Silver Carbonate Nanostructures in Wound Healing and Antibacterial Activity Against Pseudomonas chengduensis and Staphylococcus aureus
Previous Article in Journal
Perceived Changes in Anxiety Symptom Burden During Treatment with Bryophyllum pinnatum: A Prospective, Single-Arm Study
Previous Article in Special Issue
Synthesis and Application of Silver Nanoparticles for Caries Management: A Review
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(11), 1421; https://doi.org/10.3390/ph17111421
Action Date Notes Link
article xml file uploaded 24 October 2024 11:28 CEST Original file -
article xml uploaded. 24 October 2024 11:28 CEST Update https://www.mdpi.com/1424-8247/17/11/1421/xml
article pdf uploaded. 24 October 2024 11:28 CEST Version of Record https://www.mdpi.com/1424-8247/17/11/1421/pdf
article html file updated 24 October 2024 11:30 CEST Original file https://www.mdpi.com/1424-8247/17/11/1421/html
Back to TopTop